Ironwood Pharma (IRWD) Tops Q3 EPS by 6c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. WDC
3. DECK
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. FIX

Go back to Ironwood Pharma (IRWD) Tops Q3 EPS by 6c

Ironwood Pharmaceuticals Provides Third Quarter 2017 Investor Update

November 2, 2017 8:05 AM EDT

Ironwood revenue grew 31% to $87 million in 3Q 2017 over 3Q 2016

LINZESS® (linaclotide) U.S. net sales increased 16% to $191 million and net profit increased 36% to $111 million in 3Q 2017 over 3Q 2016

Launched DUZALLO® (lesinurad and allopurinol), a once-daily fixed-dose combination treatment for patients with uncontrolled gout

Advanced innovative development candidates with positive IW-3718 Phase IIb trial results and initiation of IW-1973 Phase II trials in diabetic nephropathy and HFpEF

CAMBRIDGE, Mass.--(BUSINESS WIRE)--... More